# Mark Bounthavong, Pharm.D., Ph.D., M.P.H.

**Source**: https://pharmacy.ucsd.edu/faculty/bounthavong
**Parent**: https://pharmacy.ucsd.edu/admissions/career-opportunities

#### Associate Professor of Clinical Pharmacy Skaggs School of Pharmacy and Pharmaceutical Sciences

Email

mbounthavong@health.ucsd.edu

Research Summary

Dr. Bounthavong’s research interests include pharmacoeconomics, program and implementation evaluations, applied econometrics, and evidence-synthesis using Bayesian methods. More recently, Dr. Bounthavong’s research has centered around evaluating academic detailing’s impact on aligning provider’s behavior with evidence-based practice, particularly with the opioid epidemic.

Academic Achievements

**Education**: B.S. in Biological Sciences (1999) University of California, Irvine; PharmD (2004) Western University of Health Sciences College of Pharmacy; PGY1 Pharmacy Practice Residency (2005) VA Loma Linda Medical Center; Pharmacoeconomics and Outcomes Research Fellowship (2007) Western University of Health Sciences College of Pharmacy; Master of Public Health (2013) Emory University Rollins School of Public Health; PhD (2018) University of Washington, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute.

**Awards and Honors**: Best Paper Award (2018) Vancouver Health Economics Methodology Meeting, Vancouver, Canada; U.S. Under Secretary of Health Pharmacy Practice Innovation Award (2009, 2017), U.S. Department of Veterans Affairs; American Society of Health-System Pharmacists Best Practice Award (2009, 2017); Alumni Achievement Award (2016) 20th Anniversary Gala Celebration. College of Pharmacy, Western University of Health Sciences; AHRQ T32 Fellowship (2013-2015) Agency for Healthcare Research and Quality T32 PhD Student training grant#T32HS013853; American Society of Health-System Pharmacists Literature (Best Paper) Award (2010); Distinguish Service Award (2009) Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific.

**Leadership Experience**: Associate Editor (2020-present), Substance Abuse journal (SAj) Print ISSN: 0889-7077; Online ISSN: 1547-0164; Editorial Advisory Board Member (2021-present), Journal of the American Pharmacist Association. Print ISSN: 1544-3191; Online ISSN: 1544-3450; Chair (2019-present), Pharmacy Evaluation-Research Selection Committee, VA Pharmacy Benefits Management Academic Detailing Service; Chair (2021-present) and Steering Committee Member (2018-present), New Professions Steering Committee, International Society for Pharmacoeconomics and Outcomes Research; Director, PGY1 Managed Care Pharmacy Residency (2008-2013) Veterans Affairs San Diego Healthcare System.

Teaching

- Chair, SPPS 209 – Applied Pharmacoeconomics SPPS 209
- Co-chair, SPPS 206 – Study Design and Biostatistics I
- Co-chair, SPPS 208 – Study Design and Biostatistics II

Key Contributions

- Published data used by the U.S. Office of the Inspector General’s Report on the opioid crisis
- Implemented and maintained the first pharmacist-run immunization clinic at the Veterans Health Administration
- Developed national formulary monographs for VA Pharmacy Benefits Management
- Contributed (economic analysis) to the establishment of the first emergency department pharmacist position at the Veterans Health Administration

Selected Publications

- Bounthavong M, Lau MK, Kay CL, et al. (2021). [Impact of Implementing an Academic Detailing Program on Opioid-Benzodiazepine Co-Prescribing Trends at the U.S. Department of Veterans Affairs. *Pain Med* 22(6):1426-1434.](https://pubmed.ncbi.nlm.nih.gov/33749779/)
- Bounthavong M, Lau MK, Popish SJ, et al. (2020). [Impact of academic detailing on benzodiazepine use among veterans with posttraumatic stress disorder. *Subst Abus.* 41(1):101-109](https://pubmed.ncbi.nlm.nih.gov/30870137/).
- Bounthavong M. et al. (2019) [Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration. *Health Serv Res.* 54(5):1055-1064.](https://pubmed.ncbi.nlm.nih.gov/31313839/)
- Bounthavong M, Butler J, Dolan CM, et al. (2018).  [Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia. Pharmacoeconomics. 36(12):1463-1473.](https://pubmed.ncbi.nlm.nih.gov/30194623/)
- Bounthavong M, Harvey MA, Wells DL, et al. (2017. [Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis. *J Am Pharm Assoc* 57(2S):S68-S72.](https://pubmed.ncbi.nlm.nih.gov/28089521/)
- Aldridge VE, Park HK, Bounthavong M, Morreale AP. (2009)  [Implementing a comprehensive, 24-hour emergency department pharmacy program. *Am J Health Syst Pharm.* 66(21):1943-1947.](https://pubmed.ncbi.nlm.nih.gov/19850790/)

      **[(view more)](https://pubmed.ncbi.nlm.nih.gov/?term=Bounthavong+M)**